Literature DB >> 1747018

The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy.

J J Mann1, S Kapur.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1747018     DOI: 10.1001/archpsyc.1991.01810350067011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  14 in total

1.  Measurement-based care for unipolar depression.

Authors:  David W Morris; Madhukar H Trivedi
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

Review 2.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

Review 3.  Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.

Authors:  P Mourilhe; P E Stokes
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

4.  The Food and Drug Administration's deliberations on antidepressant use in pediatric patients.

Authors:  Laurel K Leslie; Thomas B Newman; P Joan Chesney; James M Perrin
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

Review 5.  Prevention of suicide: aspirations and evidence.

Authors:  D Gunnell; S Frankel
Journal:  BMJ       Date:  1994-05-07

6.  Systematic review and guide to selection of selective serotonin reuptake inhibitors.

Authors:  J G Edwards; I Anderson
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

7.  The Fluoxetine and Suicide Controversy : A Review of the Evidence.

Authors:  D Healy
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

Review 8.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.

Authors:  M G Harris; P Benfield
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 9.  Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness.

Authors:  M I Wilde; G L Plosker; P Benfield
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

Review 10.  Suicidal behaviour in bipolar disorder: risk and prevention.

Authors:  Leonardo Tondo; Göran Isacsson; Ross Baldessarini
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.